CCK-8 [Ligand Id: 864] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1121 (SQ 19844, Pancreozymin, Cholecystokinin, SQ-19844, Sincalide, Kinevac, Cholecystokinin c-terminal octapeptide)
  • CCK1 receptor/Cholecystokinin A receptor in Human [ChEMBL: CHEMBL1901] [GtoPdb: 76] [UniProtKB: P32238]
  • CCK1 receptor/Cholecystokinin A receptor in Rat [ChEMBL: CHEMBL2871] [GtoPdb: 76] [UniProtKB: P30551]
  • Cholecystokinin A receptor in Guinea pig [ChEMBL: CHEMBL3501] [UniProtKB: Q63931]
  • 9.19
1 CHEMBL1121_lig_chart_1 Cholecystokinin A receptor HumanRatGuinea pig
There should be some charts here, you may need to enable JavaScript!
  • CCK2 receptor/Cholecystokinin B receptor in Human [ChEMBL: CHEMBL298] [GtoPdb: 77] [UniProtKB: P32239]
  • CCK2 receptor/Cholecystokinin B receptor in Mouse [ChEMBL: CHEMBL2854] [GtoPdb: 77] [UniProtKB: P56481]
  • CCK2 receptor/Cholecystokinin B receptor in Rat [ChEMBL: CHEMBL3508] [GtoPdb: 77] [UniProtKB: P30553]
  • 9.22
2 CHEMBL1121_lig_chart_2 Cholecystokinin B receptor HumanMouseRat
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
CCK1 receptor/Cholecystokinin A receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1901] [GtoPdb: 76] [UniProtKB: P32238]
ChEMBL Displacement of radiolabeled CCK-8s from human CCK1 receptor B 9.55 pKi 0.28 nM Ki J. Med. Chem. (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL In vitro for binding affinity against human cholecystokinin type A receptor. B 8.88 pIC50 1.32 nM IC50 J. Med. Chem. (1997) 40: 2706-2725 [PMID:9276016]
ChEMBL Binding affinity against human Cholecystokinin type A receptor by displacement of [125I]CCK-8 B 8.88 pIC50 1.32 nM IC50 J. Med. Chem. (1996) 39: 2655-2658 [PMID:8709093]
ChEMBL Binding affinity against human Cholecystokinin type A receptor in membrane preparation isolated from CHO-K1 cells stably transfected with cDNA of human CCK-A using [125I]-Bolton-Hunter CCK-8 as radioligand B 8.88 pIC50 1.32 nM IC50 J. Med. Chem. (1996) 39: 3030-3034 [PMID:8709137]
ChEMBL Tested for the 50% displacement of [125I]CCK-8 from membrane preparation isolated from CHO-K1 cells stably transfected with the cDNA of human Cholecystokinin type A receptor B 8.9 pIC50 1.26 nM IC50 Bioorg. Med. Chem. Lett. (1997) 7: 511-514
ChEMBL Compound was tested in vitro for its ability to displace [125I]Bolton-Hunter CCK-8 from membrane preparation isolated from CHO-KI cells stably transfected with cDNA of human Cholecystokinin type A receptor B 9.2 pIC50 0.63 nM IC50 J. Med. Chem. (1996) 39: 5236-5245 [PMID:8978852]
ChEMBL Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cells B 9.2 pIC50 0.63 nM IC50 J. Med. Chem. (1996) 39: 562-569 [PMID:8558528]
ChEMBL Displacement of CCK-8 from CHO cell membranes expressing human Cholecystokinin type A receptor B 9.4 pIC50 0.4 nM IC50 J. Med. Chem. (1995) 38: 207-211 [PMID:7837233]
ChEMBL In vitro displacement of [125I]BH-CCK-8 from cDNA of human Cholecystokinin type A receptor expressed in CHO-K1 cells B 9.41 pIC50 0.39 nM IC50 J. Med. Chem. (1995) 38: 3384-3390 [PMID:7650691]
ChEMBL Displacement of radiolabeled CCK-8s from human CCK1 receptor B 9.43 pIC50 0.37 nM IC50 J. Med. Chem. (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL Displacement of [125I]CCK-8s from human recombinant CCK-A receptor expressed in CHO cells B 9.89 pIC50 0.13 nM IC50 Bioorg. Med. Chem. (2016) 24: 1793-1810 [PMID:26988801]
ChEMBL Displacement of [125I]CCK-8s from human recombinant CCK1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method B 9.89 pIC50 0.13 nM IC50 Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250]
ChEMBL Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay B 9.95 pIC50 0.11 nM IC50 J Med Chem (2019) 62: 1407-1419 [PMID:30624060]
ChEMBL Antagonist activity at CCK1 receptor expressed in HEK 293 cells assessed as accumulation of [3H]inositol phosphates by PI assay F 7.55 pEC50 28.18 nM EC50 J. Med. Chem. (2006) 49: 2868-2875 [PMID:16686530]
ChEMBL Antagonist activity at CCK1 receptor expressed in HEK 293 cells assessed as accumulation of [3H]inositol phosphates by PI assay F 7.55 pEC50 28 nM EC50 J. Med. Chem. (2006) 49: 2868-2875 [PMID:16686530]
ChEMBL Compound was evaluated for the [Ca2+] mobilization innstably transfected CHO-K1 cell lines expressing human Cholecystokinin type A receptor B 10 pEC50 0.1 nM EC50 J. Med. Chem. (1995) 38: 3384-3390 [PMID:7650691]
ChEMBL Agonist activity at human CCK1R expressed in human 1321N1 cells assessed as IP1 accumulation after 1 hr by HTRF assay B 10.36 pEC50 0.04 nM EC50 J Med Chem (2019) 62: 1407-1419 [PMID:30624060]
CCK1 receptor/Cholecystokinin A receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2871] [GtoPdb: 76] [UniProtKB: P30551]
ChEMBL Evaluated for binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in rat pancreas membranes at a KD concentration of 4.4 nM B 8.06 pKi 8.71 nM Ki J. Med. Chem. (1987) 30: 962-968 [PMID:2438407]
ChEMBL Inhibition of [3H]pCCK-8 specific binding to Cholecystokinin type A receptor of rat pancreas B 9.28 pKi 0.52 nM Ki J. Med. Chem. (1997) 40: 3402-3407 [PMID:9341915]
ChEMBL Binding affinity for Cholecystokinin type A receptor using [125I]BH-CCK-8 in rat pancreatic tissue B 10.05 pKi 0.09 nM Ki J. Med. Chem. (1997) 40: 4302-4307 [PMID:9435899]
ChEMBL Inhibition of [125I]BH-CCK-8 binding to Cholecystokinin type A receptor of rat pancreatic tissue B 10.05 pKi 0.09 nM Ki J. Med. Chem. (2000) 43: 2350-2355 [PMID:10882360]
GtoPdb - - 7.2 pIC50 - - - Proc Natl Acad Sci USA (1990) 87: 6728-32 [PMID:1975695]
ChEMBL Tested for the inhibition of specific [3H]propionyl-CCK-8 binding to rat pancreas membrane(CCK-A) B 8.97 pIC50 1.08 nM IC50 Bioorg. Med. Chem. Lett. (1997) 7: 855-860
ChEMBL Binding affinity by competitive inhibition of the radioligand [3H]pCCK-8 at Cholecystokinin type A receptor from rat pancreas B 8.98 pIC50 1.04 nM IC50 J. Med. Chem. (1999) 42: 4659-4668 [PMID:10579828]
ChEMBL Inhibition of [3H]pCCK-8 binding to cholecystokinin type A receptor of rat pancreas B 8.98 pIC50 1.04 nM IC50 J. Med. Chem. (2001) 44: 4196-4206 [PMID:11708921]
ChEMBL Inhibition of [3H]-pCCK-8 binding to Cholecystokinin type A receptor of rat pancreas homogenates B 8.98 pIC50 1.04 nM IC50 J. Med. Chem. (2004) 47: 5318-5329 [PMID:15456276]
ChEMBL Compound was evaluated for the binding affinity towards rat pancreatic Cholecystokinin type A receptor B 9 pIC50 1 nM IC50 Bioorg. Med. Chem. Lett. (2000) 10: 1245-1248 [PMID:10866391]
ChEMBL Displacement of 125I]-D-Tyr-Gly-[(Nle28,31)CCK-26-33] from rat cell membrane Cholecystokinin type A receptor B 9.1 pIC50 0.8 nM IC50 Bioorg. Med. Chem. Lett. (1998) 8: 3127-3132 [PMID:9873689]
ChEMBL Concentration required to inhibit by 50% specific binding of [125I](BH)-CCK-8 to cholecystokinin type A receptor in rat pancreatic acini B 9.3 pIC50 0.5 nM IC50 J. Med. Chem. (1992) 35: 28-38 [PMID:1732532]
GtoPdb - - 9.9 pIC50 - - - Proc Natl Acad Sci USA (1990) 87: 6728-32 [PMID:1975695]
ChEMBL Inhibition of [125I]- Bolton-Hunter CCK-26-33 binding to Cholecystokinin type A receptor of rat pancreas B 10 pIC50 0.1 nM IC50 Bioorg. Med. Chem. Lett. (1993) 3: 889-894
ChEMBL Half-maximal inhibition of specific binding of [125I]bolton hunter CCK-8 to rat pancreas cholecystokinin type A receptor B 10 pIC50 0.1 nM IC50 J. Med. Chem. (1991) 34: 404-414 [PMID:1671419]
ChEMBL Evaluated for inhibition of cholecystokinin type A receptor by displacing [125I]bolton hunter CCK-8 radioligand in the rat pancreas B 10 pIC50 0.1 nM IC50 J. Med. Chem. (1992) 35: 2573-2581 [PMID:1635058]
ChEMBL Inhibition of binding of [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type A receptor in the rat pancreas. B 10 pIC50 0.1 nM IC50 J. Med. Chem. (1993) 36: 552-565 [PMID:7684452]
Cholecystokinin A receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3501] [UniProtKB: Q63931]
ChEMBL Displacement of [3H]-pCCK-8 from cholecystokinin-A receptor in guinea pig pancreatic membrane B 9.15 pKi 0.7 nM Ki J. Med. Chem. (1993) 36: 166-172 [PMID:8421283]
ChEMBL Compound was tested for binding affinity against CCK1 (cholecystokinin) receptor on guinea pig pancreatic membranes B 9.15 pKi 0.7 nM Ki J. Med. Chem. (2000) 43: 3614-3623 [PMID:11020275]
ChEMBL The compound was tested for the inhibition of [3H]propionyl specific binding to CCK-8 receptor of guinea pig pancreatic membrane B 9.19 pKi 0.64 nM Ki J. Med. Chem. (1989) 32: 445-449 [PMID:2464062]
ChEMBL Tested for the inhibition of [3H]pCCK-8 binding to Cholecystokinin type A receptor in pancreatic membranes of guinea-pig B 9.19 pKi 0.64 nM Ki Bioorg. Med. Chem. Lett. (1993) 3: 847-850
ChEMBL Displacement of 0.1 nM [3H]pCCK-8 from guinea pig pancreatic membranes B 9.19 pKi 0.64 nM Ki J. Med. Chem. (1989) 32: 1184-1190 [PMID:2724293]
ChEMBL Ability to displace 1 nM [3H]pCCK-8 from Cholecystokinin type A receptor in guinea pig pancreatic membranes B 9.22 pKi 0.6 nM Ki Bioorg. Med. Chem. Lett. (2004) 14: 369-372 [PMID:14698161]
ChEMBL Inhibition of [3H]pCCK-8 binding to Cholecystokinin type A receptor of Guinea pig pancreatic membranes B 9.55 pKi 0.28 nM Ki J. Med. Chem. (1997) 40: 647-658 [PMID:9057851]
ChEMBL The compound was tested for the inhibition of [3H]propionyl specific binding to CCK-8 receptor of guinea pig brain B 9.55 pKi 0.28 nM Ki J. Med. Chem. (1989) 32: 445-449 [PMID:2464062]
ChEMBL Displacement of [125I]BH-CCK-8 from Cholecystokinin type A receptor in guinea pig pancreas B 9.4 pIC50 0.4 nM IC50 J. Med. Chem. (1990) 33: 2950-2952 [PMID:1700123]
ChEMBL Displacement of [125I]Bolton-Hunter-CCK-8 from guinea pig pancreas Cholecystokinin type A receptor B 9.55 pIC50 0.28 nM IC50 Bioorg. Med. Chem. Lett. (1993) 3: 855-860
CCK2 receptor/Cholecystokinin B receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL298] [GtoPdb: 77] [UniProtKB: P32239]
ChEMBL The compound was evaluated for the inhibition of binding of [3H]-PD 140376 to Cholecystokinin type B receptor in guinea pig cortex. B 9.19 pKi 0.65 nM Ki Bioorg. Med. Chem. Lett. (1993) 3: 885-888
ChEMBL Inhibition of [3H]pCCK-8 binding to Guinea pig cortex membrane Cholecystokinin type B receptor B 9.19 pKi 0.64 nM Ki J. Med. Chem. (1997) 40: 647-658 [PMID:9057851]
ChEMBL Displacement of radiolabeled CCK-8s from human CCK2 receptor B 9.43 pKi 0.37 nM Ki J. Med. Chem. (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL Displacement of [3H]pCCK-8 from cholecystokinin type B receptor in guinea pig brain membrane B 9.52 pKi 0.3 nM Ki J. Med. Chem. (1993) 36: 166-172 [PMID:8421283]
ChEMBL Binding affinity against cholecystokinin type B receptor on guinea pig cortex. B 9.52 pKi 0.3 nM Ki J. Med. Chem. (2000) 43: 3614-3623 [PMID:11020275]
ChEMBL Inhibitory activity against Cholecystokinin type B receptor B 9.52 pKi 0.3 nM Ki Bioorg. Med. Chem. Lett. (1993) 3: 799-802
ChEMBL Tested for the inhibition of [3H]pCCK-8 binding to Cholecystokinin type B receptor in guinea pig brain B 9.55 pKi 0.28 nM Ki Bioorg. Med. Chem. Lett. (1993) 3: 847-850
ChEMBL Displacement of 0.2 nM [3H]pCCK-8 from guinea pig brain membranes B 9.55 pKi 0.28 nM Ki J. Med. Chem. (1989) 32: 1184-1190 [PMID:2724293]
ChEMBL Displacement of [125I]BH-CCK-8 from Cholecystokinin type B receptor of guinea pig cortex B 8.09 pIC50 8.2 nM IC50 J. Med. Chem. (1990) 33: 2950-2952 [PMID:1700123]
ChEMBL Displacement of [125I]Bolton-Hunter-CCK-8 from guinea pig cortex Cholecystokinin type B receptor B 8.8 pIC50 1.6 nM IC50 Bioorg. Med. Chem. Lett. (1993) 3: 855-860
ChEMBL Displacement of radiolabeled CCK-8s from human CCK2 receptor B 9.04 pIC50 0.92 nM IC50 J. Med. Chem. (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL Binding affinity against human Cholecystokinin type B receptor in CHO-K1 cells using [125I]-Bolton-Hunter CCK-8 as radioligand B 9.46 pIC50 0.35 nM IC50 J. Med. Chem. (1996) 39: 3030-3034 [PMID:8709137]
ChEMBL In vitro for binding affinity against human cholecystokinin type B receptor. B 9.46 pIC50 0.35 nM IC50 J. Med. Chem. (1997) 40: 2706-2725 [PMID:9276016]
ChEMBL Tested for 50% displacement of [125I]CCK-8 from membrane preparation isolated from CHO-K1 cells stably transfected with the cDNA of human Cholecystokinin type B receptor B 9.5 pIC50 0.32 nM IC50 Bioorg. Med. Chem. Lett. (1997) 7: 511-514
ChEMBL Compound was tested in vitro for its ability to displace [125I]Bolton-Hunter CCK-8 from membrane preparation isolated from CHO-KI cells stably transfected with cDNA of human Cholecystokinin type B receptor B 9.5 pIC50 0.32 nM IC50 J. Med. Chem. (1996) 39: 5236-5245 [PMID:8978852]
ChEMBL Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor stably expressed in CHO-K1 cells B 9.5 pIC50 0.32 nM IC50 J. Med. Chem. (1996) 39: 562-569 [PMID:8558528]
ChEMBL Displacement of CCK-8 from human Cholecystokinin type B receptor expressing CHO cell membranes B 9.5 pIC50 0.32 nM IC50 J. Med. Chem. (1995) 38: 207-211 [PMID:7837233]
ChEMBL In vitro displacement of [125I]BH-CCK-8 from cDNA of human Cholecystokinin type B receptor expressed in CHO-K1 cells B 9.5 pIC50 0.32 nM IC50 J. Med. Chem. (1995) 38: 3384-3390 [PMID:7650691]
ChEMBL Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay B 9.54 pIC50 0.29 nM IC50 J Med Chem (2019) 62: 1407-1419 [PMID:30624060]
ChEMBL Binding affinity against human Cholecystokinin type B receptor by displacement of [125I]CCK-8 B 9.64 pIC50 0.23 nM IC50 J. Med. Chem. (1996) 39: 2655-2658 [PMID:8709093]
ChEMBL Displacement of [125I]CCK-8s from human recombinant CCK-B receptor expressed in CHO cells B 9.92 pIC50 0.12 nM IC50 Bioorg. Med. Chem. (2016) 24: 1793-1810 [PMID:26988801]
ChEMBL Displacement of [125I]CCK-8s from human recombinant CCK2 receptor expressed in CHO cells measured after 60 mins by scintillation counting method B 9.92 pIC50 0.12 nM IC50 Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250]
GtoPdb - - 10 pIC50 - - - J Biol Chem (1993) 268: 8164-9 [PMID:7681836];
J Biol Chem (1993) 268: 18300-5 [PMID:8349705]
ChEMBL Antagonist activity at CCK2 receptor expressed in HEK293 cells assessed as accumulation of [3H]inositol phosphates by PI assay F 7.57 pEC50 27 nM EC50 J. Med. Chem. (2006) 49: 2868-2875 [PMID:16686530]
ChEMBL Antagonist activity at CCK2 receptor expressed in HEK293 cells assessed as accumulation of [3H]inositol phosphates by PI assay F 7.57 pEC50 26.92 nM EC50 J. Med. Chem. (2006) 49: 2868-2875 [PMID:16686530]
ChEMBL Agonist activity at human CCK2R expressed in human 1321N1 cells assessed as IP1 accumulation after 1 hr by HTRF assay B 9.3 pEC50 0.5 nM EC50 J Med Chem (2019) 62: 1407-1419 [PMID:30624060]
ChEMBL Displacement of [125I]CCK-8 from CCK2 receptor in human FGS7 Jurkat cells B 10.03 pEC50 0.09 nM EC50 J. Nat. Prod. (2006) 69: 432-435 [PMID:16562853]
ChEMBL Compound was evaluated for the [Ca2+] mobilization innstably transfected CHO-K1 cell lines expressing human Cholecystokinin type B receptor B 10.3 pEC50 0.05 nM EC50 J. Med. Chem. (1995) 38: 3384-3390 [PMID:7650691]
CCK2 receptor/Cholecystokinin B receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2854] [GtoPdb: 77] [UniProtKB: P56481]
ChEMBL In vitro binding affinity against Cholecystokinin type B receptor in mouse cerebral cortical membranes using [125I]Tyr(SO3H)27]-CCK-8 binding assay B 8.89 pIC50 1.3 nM IC50 Bioorg. Med. Chem. Lett. (2001) 11: 705-709 [PMID:11266174]
ChEMBL Evaluated for inhibition of cholecystokinin type B receptor by displacing [125I]-Bolton hunter CCK-8 radioligand in the mouse cerebral cortex B 9.52 pIC50 0.3 nM IC50 J. Med. Chem. (1992) 35: 2573-2581 [PMID:1635058]
ChEMBL Inhibition of binding of [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex B 9.52 pIC50 0.3 nM IC50 J. Med. Chem. (1993) 36: 552-565 [PMID:7684452]
ChEMBL Binding affinity towards Cholecystokinin type B receptor in mouse cortex membrane B 9.52 pIC50 0.3 nM IC50 Bioorg. Med. Chem. Lett. (2000) 10: 1245-1248 [PMID:10866391]
ChEMBL Half-maximal inhibition of specific binding of [125I]bolton hunter CCK-8 to mouse cerebral cortex cholecystokinin type B receptor B 9.52 pIC50 0.3 nM IC50 J. Med. Chem. (1991) 34: 404-414 [PMID:1671419]
ChEMBL Inhibition of [125I]- Bolton-Hunter CCK-26-33 binding to Cholecystokinin type B receptor of mouse cerebral cortex B 9.52 pIC50 0.3 nM IC50 Bioorg. Med. Chem. Lett. (1993) 3: 889-894
CCK2 receptor/Cholecystokinin B receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3508] [GtoPdb: 77] [UniProtKB: P30553]
ChEMBL Inhibition of [3H]- pCCK-8 binding to Cholecystokinin type B receptor of rat cerebral cortex membranes B 8.55 pKi 2.8 nM Ki J. Med. Chem. (1997) 40: 3402-3407 [PMID:9341915]
ChEMBL Ability to displace 1 nM [3H]pCCK-8 from rat Cholecystokinin type B receptor stably expressing in CHO cells B 9.15 pKi 0.7 nM Ki Bioorg. Med. Chem. Lett. (2004) 14: 369-372 [PMID:14698161]
ChEMBL Affinity to inhibit [3H]pCCK-8 specific binding on rat brain Cholecystokinin type B receptor expressed in CHO cells B 9.22 pKi 0.6 nM Ki J. Med. Chem. (1997) 40: 647-658 [PMID:9057851]
ChEMBL Compound was tested for binding affinity against Cholecystokinin type B receptor expressed in CHO cells on the rat brain. B 9.22 pKi 0.6 nM Ki J. Med. Chem. (2000) 43: 3614-3623 [PMID:11020275]
ChEMBL Binding affinity for Cholecystokinin type B receptor using [125I]-BH-CCK-8 in rat cortex synaptosomes B 9.39 pKi 0.41 nM Ki J. Med. Chem. (1997) 40: 4302-4307 [PMID:9435899]
ChEMBL Binding affinity towards Cholecystokinin type B receptor in rat cortex synaptosomes using [125I]BH-CCK-8 as radioligand B 9.39 pKi 0.41 nM Ki J. Med. Chem. (2000) 43: 2350-2355 [PMID:10882360]
ChEMBL Tested for the inhibition of specific [3H]propionyl-CCK-8 binding to rat cerebral cortex membrane(CCK-B) B 8.22 pIC50 6 nM IC50 Bioorg. Med. Chem. Lett. (1997) 7: 855-860
ChEMBL Binding affinity by competitive inhibition of the radioligand [3H]pCCK-8 at Cholecystokinin type B receptor from rat cerebral cortex membrane B 8.25 pIC50 5.6 nM IC50 J. Med. Chem. (1999) 42: 4659-4668 [PMID:10579828]
ChEMBL Inhibition of [3H]pCCK-8 binding to cholecystokinin type B receptor of rat cerebral cortex B 8.25 pIC50 5.6 nM IC50 J. Med. Chem. (2001) 44: 4196-4206 [PMID:11708921]
ChEMBL Inhibition of [3H]-pCCK-8 binding to Cholecystokinin type B receptor of rat cerebral cortex homogenates B 8.25 pIC50 5.6 nM IC50 J. Med. Chem. (2004) 47: 5318-5329 [PMID:15456276]
ChEMBL Inhibition of the specific binding of [125I](BH)-CCK-8 to Cholecystokinin type B receptor in rat brain cortex B 9 pIC50 1 nM IC50 J. Med. Chem. (1992) 35: 28-38 [PMID:1732532]
ChEMBL Effective concentration for the stimulation of Inositol Phosphate accumulation in CHO cells expressing wild-type Cholecystokinin type B receptor F 9.2 pEC50 0.63 nM EC50 J. Med. Chem. (1997) 40: 647-658 [PMID:9057851]
ChEMBL Affinity against Cholecystokinin type B receptor expressed in CHO cells on rat brain. F 9.2 pEC50 0.63 nM EC50 J. Med. Chem. (2000) 43: 3614-3623 [PMID:11020275]

ChEMBL data shown on this page come from version 28:

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]